News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Mrinal Patnaik: ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact
Photo of Mrinal Patnaik from mayo.edu
Jun 27, 2024, 02:57

Mrinal Patnaik: ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact

Mrinal Patnaik, Physician Scientist with the Division of Hematology, Department of Internal Medicine at Mayo Clinic, Minnesota, shared a post on X:

“ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions.”

Mrinal Patnaik

Source: Mrinal Patnaik/X

ASXL1/TET2 cancer Mayo Clinic Mrinal Patnaik OncoDaily Oncology
Special Coverage
Blog
Feb 25, 2025, 05:11
MD Anderson receives nearly $23 million in CPRIT funding for cancer research, faculty recruitment
Insight
Feb 24, 2025, 23:46
Cancer death rates almost 60% higher in UK’s most deprived areas - Cancer Research UK
Blog
Feb 24, 2025, 23:27
Xiuning Le: Honored to serve as a co-chair for IASLC TTLC 2026 and 2027
Blog
Feb 24, 2025, 21:24
ICCD 2025 Event Highlights: Speakers’ Quote Series with Ruth Ladenstein - SIOP Europe
Blog
Feb 24, 2025, 15:25
Bibhudatta Mishra: A paradigm shift in oncology
Blog
Feb 24, 2025, 14:55
Esra Bilir: Women Empowerment at ESGO2025
Blog
Feb 24, 2025, 14:51
Celebrating the Black Volunteer Caucus - ACS CAN
Blog
Feb 24, 2025, 14:45
How can radiotherapy become more environmentally friendly? - ESMO
Blog
Feb 24, 2025, 14:22
Vincent Ling: Where does the money go?
Science
Feb 24, 2025, 14:08
JeeSuk Chang: The 2nd analysis of SABR-5
Stories
Feb 24, 2025, 14:00
Remembering Giovanni Scambia: A Legacy in Gynecological Oncology
Insight
Feb 24, 2025, 13:59
Women in Thoracic Surgery Board of Directors